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Abstract: The CHRNA5-CHRNA3-CHRNB4 gene cluster on chromosome 15q25.1 encoding the cholinergic nicotinic 
receptor subunits is robustly associated with smoking behavior and nicotine dependence. Only a few studies to 
date have examined the locus with alcohol related traits and found evidence of association with alcohol abuse and 
dependence. Our main goal was to examine the role of three intensively studied single nucleotide polymorphisms, 
rs16969968, rs578776 and rs588765, tagging three distinct loci, in alcohol use. Our sample was drawn from two 
independent Finnish population-based surveys, the National FINRISK Study and the Health 2000 (Health Examina-
tion) Survey. The combined sample included a total of 32,592 adult Finns (54% women) of whom 8,356 were as-
sessed for cigarettes per day (CPD). Data on alcohol use were available for 31,812 individuals. We detected a novel 
association between rs588765 and alcohol use defined as abstainers and low-frequency drinkers versus drinkers 
(OR=1.15, p=0.00007). Additionally, we provide precise estimates of strength of the association between the three 
loci and smoking quantity in a very large population based sample. As a conclusion, our results provide further evi-
dence for the nicotine-specific role of rs16969968 (locus 1). Further, our data suggest that the effect of rs588765 
(locus 3) may be specific to alcohol use as the effect is seen also in never smokers. 
Keywords: Nicotinic acetylcholine receptors, 15q25.1, alcohol use, smoking behavior, public health, population-
based sample, genetic association
Introduction
Smoking, alcohol use and abuse are serious 
public health issues [1, 2]. Both genetic and 
environmental factors clearly are of importance 
in accounting for inter-individual differences in 
these common behaviors. Family and twin 
studies show that alcohol use, abuse, and 
dependence as well as smoking and nicotine 
dependence are transmitted within families [3, 
4]. Smoking and alcohol use often co-occur, 
suggesting that they may have a shared genetic 
predisposition [5]. However, the molecular 
genetic basis for that shared predisposition is 
still largely unknown. 
Within the past few years, genetic findings for 
nicotine dependence and other smoking relat-
ed traits and diseases have pinpointed a region 
on chromosome 15q25.1. This region harbors 
the CHRNA5-CHRNA3-CHRNB4 gene cluster 
coding for a5, a3, and b4 nicotinic acetylcholine 
receptor (nAChR) subunits. Evidence of associa-
tion with smoking behavior and nicotine depen-
dence has been reported in a genome-wide 
association study (GWAS) [6] and confirmed in 
CHRNA5-CHRNA3-CHRNB4 locus associated with alcohol use
110 Int J Mol Epidemiol Genet 2013;4(2):109-119
large meta-analyses conducted by indepen-
dent consortia [7-10]. The most well-estab-
lished locus within this region is tagged by the 
single nucleotide polymorphism (SNP) 
rs16969968 (locus 1) [11]. Rs16969968 is a 
non-synonymous (D398N) SNP in exon 5 of 
CHRNA5, located in the cytoplasmic domain 
preceding the M4 transmembrane domain [12]. 
Asparagine (N) in the 398 position with its polar 
uncharged side chain lowers Ca2+ permeability 
and increases short-term desensitization in 
(α4β2)α5 nAChRs [12]. When the function of 
the subunit is decreased, α5-containing 
nAChRs fail to trigger a normal inhibitory moti-
vational signal that is supposed to limit nicotine 
intake [13]. 
Three distinct loci tagged by rs16969968 
(locus 1), rs578776 (locus 2), and rs588765 
(locus 3) provided evidence of association with 
smoking amount defined by cigarettes per day 
(CPD) in a meta-analysis of 38,617 smokers 
from 34 data-sets [7]. Three other meta-analy-
ses detected association with locus 1 and 
locus 2 but no independent effect was detect-
ed for locus 3 [8-10], which emphasizes the 
need for further studies. Both locus 1 and locus 
2 have been associated also with nicotine 
dependence defined by the Fagerström Test for 
Nicotine Dependence (FTND [14]) [15], and by 
the Diagnostic and Statistical Manual of Mental 
Disorders 4th edition (DSM-IV [16]) [17, 18], 
with the minor allele of rs16969968 (locus 1) 
increasing the risk, and the minor allele of 
rs578776 (locus 2) exhibiting a protective 
effect. 
A few studies have reported association of this 
region with alcohol related traits, with some-
what discordant results. Chen and colleagues 
[19] found evidence of association between 
locus 1 (rs16969968) and symptoms of alco-
hol abuse or dependence. Wang and colleagues 
[20] observed association between DSM-IV 
alcohol dependence and a narrow region that 
included locus 3 (rs588765); however, no asso-
ciation was detected with locus 1 (rs16969968) 
or locus 2 (rs578776). Sherva and colleagues 
[17] detected association between DSM-IV 
alcohol dependence and locus 2 (rs578776) 
and locus 3 (rs615470), when using an African-
American sample, while their European-
American sample provided no evidence of 
association. On top of the studies focusing on 
alcohol dependence, one study has reported 
association between alcohol initiation and two 
CHRNB4 SNPs (rs1948 and rs11634351) in 
young Americans of European descent [21]. 
The incongruity may in part be due to heteroge-
neity and varying linkage disequilibrium (LD) 
structures between the study samples. To date 
there have been no published studies of alco-
hol use with respect to this gene cluster; thus, 
further studies are needed to clarify whether 
genetic variation in the nAChR genes contrib-
utes to inter-individual differences in alcohol 
use.
Our first aim was to replicate in a large popula-
tion-based sample the results of the meta-
analysis of Saccone and colleagues [7] report-
ing an association between three distinct loci 
at 15q25.1 and smoking quantity, thus provid-
ing precise estimates of the strength of the 
association in the population at large. The sec-
ond aim, our main goal, was to study the role of 
genetic variants on 15q25.1 in alcohol use and 




Our sample was drawn from two independent 
Finnish population-based surveys, the National 
FINRISK Study [25] and the Health 2000 
(Health Examination) Survey [26]. 
The National FINRISK Study has been initiated 
in 1972 and carried out since then every five 
years using independent, random, and repre-
sentative samples from four to six different 
parts of Finland depending on the year of the 
survey [25]. We used data from cohorts 1992, 
1997, 2002, and 2007 (participation rates 
76%, 72%, 69% and 65%, respectively), com-
prising of 26,800 genotyped subjects (53% 
women) with self-reported information about 
their health-related habits, including tobacco 
and alcohol use. The mean age was 48 years.
The Health 2000 population based survey was 
carried out during 2000-2001 in Finland (par-
ticipation rate 76%), as previously described 
[26]. This random and representative sample 
included 5,792 genotyped subjects (55% 
women) with self-reported information about 
their health-related habits, including tobacco 
and alcohol use. The mean age was 54 years. 
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As the marker frequencies did not significantly 
vary between study regions (i.e., no population 
stratification was detected) and time of the 
cross-sectional survey, these factors were not 
included in the final analyses. Thus, we com-
bined the FINRISK and Health 2000 samples, 
resulting in a total study sample of 32,592 
adult Finns (54% women) aged 25 to 98 years. 
The mean age was 49 years. A flow chart of the 
sample is presented in Figure 1.
Smoking quantity traits
The smoking quantity traits were derived from 
quantitative self-reported measure of ciga-
rettes smoked per day (CPD), administered to 
current (including daily and occasional) and for-
mer smokers. In both FINRISK and Health 2000 
samples, the participants were asked: “How 
many cigarettes (either manufactured or self-
rolled cigarettes, or equivalent amounts of 
cigars or pipe tobacco) do you smoke daily or 
smoked before quitting?”. The answers were 
summed as one quantitative measure of CPD 
which was analyzed as a quantitative trait and 
as a dichotomous trait with light smoking “con-
trols” (CPD≤10; N=3,624), and heavy smoking 
“cases” (CPD>20; N=1,076), as used by 
Saccone and colleagues [7]. The case/control 
designation is considered as a proxy for nico-
tine dependence, as nicotine dependence was 
not otherwise assessed in the entire data. In 
the combined data set of 32,592 subjects 
there were 667 (2%) individuals who reported 
zero CPD. Among these individuals there were 
197 former smokers and 470 current smokers 
(this category included daily and occasional 
smokers). We excluded these 667 individuals 
from our analyses due to the ambiguity in their 
questionnaire answers.
Alcohol use traits
In the analyses of alcohol consumption, we 
examined weekly alcohol consumption as 
quantitative, categorical, and dichotomized 
traits. In the quantitative analyses we used 
self-reported alcohol consumption defined as 
grams (g) per week with logarithmic transfor-
mation in order to approach normal distribu-
tion. Abstainers (N=11,514) were excluded 
from the analyses of quantitative alcohol con-
sumption. In the FINRISK sample, the measure 
was derived from a question: “How many glass-
es (restaurant measures) or bottles of alcohol 
beverages did you drink during last week?”. 
Figure 1. Study sample. A flow chart of the sample and variables included in the study.
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Alcohol consumption (g/week) was then calcu-
lated for each individual based on the knowl-
edge of how many grams of ethanol different 
alcohol beverages contain. In the Health 2000 
sample, respective measure was derived from 
a question: “How often and how much did you 
drink alcohol beverages during the past 12 
months?”. An average consumption of alcohol 
per week (g/week) was calculated for each indi-
vidual based on the knowledge of how many 
grams of ethanol various alcohol beverages 
contain. For both categorical and dichotomous 
alcohol use analyses the quantitative alcohol 
consumption was first coded as standard 
drinks per week; one alcohol drink was defined 
as containing 12 g of pure ethanol. In the analy-
sis of categorical alcohol trait, individuals were 
categorized as abstainers and low-frequency 
drinkers (less than 1 drink per week), light 
drinkers (1-2 drinks per week), moderate drink-
ers (3-7 drinks per week for women, and 3-14 
drinks per week for men), and heavy drinkers 
(over 7 drinks per week for women, and over 14 
drinks per week for men). For dichotomous 
alcohol use, we contrasted those drinking one 
or more drinks per week (drinkers) versus those 
Table 1. A: Association between dichotomous CPDa and CHRNA5-CHRNA3-CHRNB4 variants in the 
Finnish population sample, prevalence odds ratios (ORs) and 95% confidence intervals (95% CIs) 
from logistic regression (additive model), (B) association between quantitative CPD and CHRNA5-
CHRNA3-CHRNB4 variants in the Finnish population sample, regression coefficients (β) and 95% 
confidence intervals (CIs) from negative binomial regression (additive model)
A Light versus heavy smoking
Model 1
Adjusted for sex and age
Model 2
Model 1 + alcoholb 
(N=4,688-4,700)c (N=3,294-3,306)c
Single-SNP OR 95% CI P OR 95% CI P
Locus 1d 1.39 1.25, 1.55 1.43 x 10-9 1.42 1.25, 1.62 7.20 x 10-8
Locus 2e 0.80 0.72, 0.90 0.00005 0.83 0.73, 0.95 0.008
Locus 3f 0.91 0.81, 1.01 0.091 0.86 0.75, 0.98 0.024
Joint model OR 95% CI P OR 95% CI P
Locus 1d 1.34 1.18, 1.52 2.56 x 10-6 1.42 1.22, 1.65 2.95 x 10-6
Locus 2e 0.93 0.81, 1.06 0.262 1.00 0.85, 1.17 0.977
Locus 1d 1.49 1.30, 1.70 1.43 x 10-9 1.47 1.26, 1.73 8.77 x 10-7
Locus 3f 1.13 0.99, 1.29 0.066 1.06 0.90, 1.24 0.463
aLight (CPD≤10) versus heavy (CPD>20) smokers; bLog transformation of alcohol consumption (g/week), abstainers excluded; 
cDepending on the number of observations with both phenotype and genotype data; dTagged by rs16969968; eTagged by 
rs578776; fTagged by rs588765.
B Cigarettes per day
Model 1
Adjusted for sex and age
Model 2
Model 1 + alcohola 
(N=8,319-8,356)b (N=5,907-5,933)b
Single-SNP β 95% CI P β 95% CI P
Locus 1c 0.067 0.048, 0.086 1.11 x 10-12 0.065 0.046, 0.089 7.24 x 10-10
Locus 2d -0.042 -0.061, -0.023 6.50 x 10-6 -0.037 -0.059, -0.015 0.001
Locus 3e -0.020 -0.038, -0.002 0.028 -0.024 -0.045, -0.003 0.027
Joint model β 95% CI P β 95% CI P
Locus 1c 0.062 0.040, 0.083 7.14 x 10-9 0.065 0.040, 0.090 1.30 x 10-7
Locus 2d -0.012 -0.034, 0.009 0.266 -0.006 -0.031, 0.019 0.660
Locus 1c 0.081 0.058, 0.104 8.95 x 10-13 0.079 0.053, 0.105 2.05 x 10-9
Locus 3e 0.023 0.001, 0.045 0.036 0.019 -0.006, 0.044 0.145
aLog transformation of alcohol consumption (g/week), abstainers excluded; bDepending on the number of observations with 
both phenotype and genotype data; cTagged by rs16969968; dTagged by rs578776; eTagged by rs588765. β, co-efficient for 
the negative binomial model, i.e. they are calculated for the purpose of producing p-values and cannot be used as such for the 
estimation of effect size. (see Table 2).
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either using no alcohol at all or drinking less 
than one drink per week (i.e. less than 12 g of 
alcohol per week) (abstainers and low-frequen-
cy drinkers). 
Genotyping
Our SNPs of interest, rs16969968 (CHRNA5; 
locus 1), rs578776 (CHRNA3; locus 2), and 
rs588765 (CHRNA5; locus 3), were selected 
based on the meta-analysis of Saccone and 
colleagues [7]. DNA was derived from whole 
blood samples frozen immediately at the clini-
cal study sites. Frozen samples were trans-
ferred to the laboratory of molecular genetics 
at the National Institute of Health and Welfare 
(earlier National Public Health Institute), where 
the DNA was extracted. Genotyping of the DNA 
samples was carried out using standard proto-
cols of iPLEX Gold technology on the 
MassARRAY System (Sequenom, San Diego, 
CA, USA). The success rate was >0.99 for all 
the SNPs and they were in Hardy Weinberg 
Equilibrium (P>0.05). Minor allele frequencies 
were 0.32, 0.32, and 0.38 for rs16969968, 
rs578776, and rs588765, respectively.
Statistical analyses
The associations between the quantitative CPD 
and the three loci were modeled using negative 
binomial regression. This model provided the 
best fit for our trait distribution (data not shown; 
available upon request). The associations 
between dichotomous CPD (light versus heavy 
smokers) and the three loci were examined 
using logistic regression. All analyses were 
adjusted for age, sex, and log transformed alco-
hol use (g/week). In order to quantify the sepa-
rate and joint effects of the SNPs, we analyzed 
two series of models: each SNP separately in 
the single-SNP model, and joint models for 
locus 1 and each of the other two loci. All allele 
main effects were modeled assuming an addi-
tive effect.
In the analyses of alcohol use traits, associa-
tions with the three loci were modeled using 
linear regression (for log transformed quantita-
tive alcohol consumption (g/week)), multinomi-
al logistic regression (for categorical alcohol 
use), and logistic regression (for dichotomous 
alcohol use, i.e. abstainers and low-frequency 
drinkers versus drinkers). The analyses for all 
alcohol use traits were adjusted for age, sex, 
and CPD. 
We explored the best-fitting model for locus-
specific dominance model (recessive, domi-
nant, and additive versus co-dominant) using 
goodness of fit tests based on likelihood ratios 
of the two models. Additive model provided the 
best-fitting model for most traits and loci with 
the exception of dichotomous alcohol use and 
locus 3 (rs588765) for which the co-dominant 
model provided the best fit (data not shown). 
In order to minimize the effect of possible for-
mer alcoholics (most of who typically also have 
smoked) within the abstainers group and to 
inhibit the confounding effect of smoking, we 
performed the analysis of dichotomous alcohol 
use also among never smokers. 
All statistical analyses were performed using 
Stata 11.1 [27]. Throughout the manuscript we 
report nominal p-values.
Replication samples
In an attempt to replicate the detected novel 
association between locus 3 and alcohol use, 
we utilized two independent samples: (1) an 
Australian twin family sample (NAG-OZALC, 
N=5743), sample demographics previously 
Table 2. Estimated amount of cigarettes per daya and 95% confidence intervals (CIs) for each loci in 
the Finnish population sample
Cigarettes per day
Major allele homozygotes Heterozygotes Minor allele homozygotes
Single-SNP marginal mean of CPD 95% CI marginal mean of CPD 95% CI marginal mean of CPD 95% CI
Locus 1b 13.9 13.6, 14.2 14.8 14.5, 15.1 16.0 15.4, 16.6
Locus 2c 14.9 14.7, 15.2 14.2 13.9, 14.5 13.9 13.9, 14.5
Locus 3d 14.8 14.5, 15.1 14.3 14.0, 14.6 14.4 13.9, 14.9
aEstimates from marginal mean values based on the negative binomial regression from Model 1 in Table 1B; bTagged by rs16969968; cTagged by 
rs578776; dTagged by rs588765.
CHRNA5-CHRNA3-CHRNB4 locus associated with alcohol use
114 Int J Mol Epidemiol Genet 2013;4(2):109-119
described elsewhere [28], and (2) the Young 
Finns Study (YFS, N=1982) [29]. 
Results
Associations with smoking quantity
We replicated the established association 
between dichotomous CPD (light versus heavy 
smokers) and locus 1 (rs16969968, preva-
lence odds ratio (OR)=1.39, p=1.43 x 10-9) and 
locus 2 (rs578776, OR=0.80, p=0.00005). 
Locus 3 (rs588765) did not yield statistical sig-
nificance. When locus 1 and locus 3 were ana-
lyzed together in the joint model, the effect size 
of locus 1 increased (OR=1.49, p=1.43 x 10-9), 
and locus 3 approached statistical significance 
(OR=1.13, p=0.066). Adjustment for alcohol 
consumption had no effect on the results. The 
association results for dichotomous CPD from 
the additive model are presented in Table 1A. 
The analysis of quantitative CPD yielded similar 
results when compared to the analysis of 
dichotomous CPD. As an exception, locus 3 
achieved statistical significance (β=0.023, 
p=0.036) when analyzed in the joint model with 
locus 1. The association results for quantitative 
CPD from the additive model are presented in 
Table 1B. Distributions of CPD per genotype 
are presented in Table 2.
Associations with alcohol use
We detected no evidence of association when 
alcohol consumption was analyzed as a quanti-
tative (standard drinks per day) or as a categori-
cal (abstainers and low-frequency drinkers, 
light, moderate or heavy drinkers) phenotype. 
Further adjustment for quantitative CPD had no 
effect on the results (data not shown; available 
upon request). 
However, when alcohol use was analyzed as a 
dichotomous phenotype, with abstainers and 
low-frequency drinkers compared to those 
drinking at least one drink per week (altogether 
N=31,812), significant association with locus 3 
was detected (rs588765, OR=1.15, 
p=0.00007). Table 3 shows the results from 
the co-dominant model. When the analysis was 
repeated among never smokers (N=16,786) 
the effect size of locus 3 remained significant 
(OR=1.18, p=0.001) (Table 3).
The association between locus 3 and (dichoto-
mized) alcohol use did not replicate in the NAG-
OZALC or YFS sample (data not shown; avail-
able upon request). 
Table 3. Association between dichotomous alcohol usea and CHRNA5-CHRNA3-CHRNB4 variants in 
the Finnish population sample, prevalence odds ratios (ORs) and 95% confidence intervals (95% CIs) 
from logistic regression (co-dominant model)
Abstainers and low-frequency drinkers versus drinkers
Model 1
Adjusted for sex and age
Model 2
Model 1 among current 
smokers
Model 3
Model 1 among never 
smokers  
Model 4
Model 1 among smokers 
adjusted for CPDb
(N=31,775-31,812)c (N=7,907-7,919)c (N=16,786-16,803)c (N=8,911-8,927)c
OR 95% CI P OR 95% CI P OR 95% CI P OR 95% CI P
Locus 1d
GG 1.00 1.00 1.00 1.00
GA 0.93 0.89, 0.98 0.007 0.88 0.79, 0.97 0.014 0.96 0.90, 1.03 0.230 0.88 0.80, 0.98 0.016
AA 0.97 0.89, 1.05 0.430 1.02 0.86, 1.21 0.818 0.95 0.85, 1.06 0.368 1.02 0.87, 1.20 0.795
Locus 2e
CC 1.00 1.00 1.00 1.00
CT 0.98 0.94, 1.03 0.532 1.09 0.98, 1.21 0.110 0.96 0.90, 1.03 0.271 1.08 0.98, 1.19 0.125
TT 0.98 0.90, 1.06 0.569 1.07 0.90, 1.27 0.441 0.93 0.84, 1.04 0.217 1.07 0.91, 1.25 0.428
Locus 3f
CC 1.00 1.00 1.00 1.00
CT 1.00 0.95, 1.05 0.945 0.88 0.79, 0.98 0.018 1.04 0.97, 1.12 0.231 0.90 0.81, 0.99 0.039
TT 1.15 1.07, 1.24 0.00007 1.09 0.93, 1.28 0.259 1.18 1.07, 1.31 0.001 1.07 0.93, 1.24 0.358
aAbstainers and low-frequency drinkers (<1 drink/week) versus drinkers (≥1 drink/week); 1 drink = 12 g of alcohol; bQuantitative CPD (cigarettes 
smoked per day); cDepending on the number of observations with both phenotype and genotype data; dTagged by rs16969968; eTagged by 
rs578776; fTagged by rs588765.
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Discussion
Chromosome 15q25.1 harbors the well-estab-
lished smoking locus within the CHRNA5-
CHRNA3-CHRNB4 gene cluster. It is robustly 
associated with smoking behavior and nicotine 
dependence [7-10]. Only a few studies to date 
have examined the locus with alcohol related 
traits and found evidence of association with 
alcohol dependence [17, 20] and alcohol 
abuse/dependence [19]. We aimed to replicate 
and quantify in the population at large the 
associations between the three distinct loci on 
chromosome 15q25.1 and smoking quantity 
(defined as CPD) reported in the meta-analysis 
of Saccone and colleagues [7]. However, our 
main aim was to test whether the 15q25.1 
region shows an association with regular alco-
hol use while carefully accounting for smoking 
behavior.
First, we provide precise estimates of the 
strength of the association of locus 1 
(rs16969968), locus 2 (rs578776), and locus 3 
(rs588765) with smoking quantity in this large 
Finnish population based sample. We were 
unable to achieve statistical significance for 
locus 3 (rs588765) with dichotomous CPD, but 
detected the association with quantitative CPD. 
This is likely due to differences in power; quan-
titative CPD phenotype included 8,356 current 
smokers, while the analysis of the dichotomous 
CPD included 3,624 “cases” (smoked>20 CPD) 
and 1,076 “controls” (smoked≤10 CPD). The 
effect of rs588765 reached statistical signifi-
cance only after the locus was adjusted for 
rs16969968, as previously reported by 
Saccone and colleagues [7]. Interestingly, three 
other large consortia have been unable to 
detect strong evidence of association for 
rs588765 even when analyzed jointly with 
rs16969968 [8-10]. These three meta-analy-
ses used linear regression to test for associa-
tion with either quantitative or categorical CPD 
while Saccone and colleagues [7] used logistic 
regression to test the association with dichoto-
mous CPD. The methodological differences 
between logistic and linear regressions have 
been suggested as a reason for this discor-
dance in the results. The current study demon-
strates that association between CPD and 
locus 3 (rs588765) can be detected using 
other models as well, such as negative binomi-
al regression. This is the largest single study 
replicating the association between the three 
loci at 15q25.1 and smoking amount, providing 
estimates of the strength of the association 
comparable to those reported previously, i.e. 1 
CPD for each minor allele (Table 2). 
As alcohol use frequently co-occurs with tobac-
co use and the traits are highly correlated [22], 
we adjusted CPD analyses for alcohol con-
sumption. However, adjustment for alcohol use 
had no notable effect on the association. The 
lack of difference between the analyses with 
and without adjustment for alcohol use sug-
gests that the association signal detected in 
locus 1 is specific to smoking. This is in line 
with the finding of Wang and colleagues [20], 
who reported no evidence of association 
between locus 1 (rs16969968) and alcohol 
dependence, suggesting that the effect of 
rs16969968 is specific to smoking.
Second, we examined the association between 
quantitative alcohol consumption and the three 
loci on 15q25.1 and detected no significant 
association. Similarly, when using multiple cat-
egories of alcohol use, no association was 
seen. In contrast, the dichotomous alcohol use, 
defined as abstainers and low-frequency drink-
ers (N=12,246) versus drinkers (N=19,566), 
showed an association with locus 3 (rs588765). 
Being a drinker was more frequent among indi-
viduals homozygous for the minor allele, while 
the same genotype exhibited a protective effect 
against heavy smoking. However, in the joint 
model with locus 1, locus 3 appeared as a risk 
factor for heavy smoking. Here, it should be 
noted that abstainers and low-frequency drink-
ers are a heterogeneous group of subjects as 
this category may contain also former alcohol-
ics who are abstaining at the time of the data 
collection. To address this as a possible con-
founder, we repeated the analysis among nev-
er-smokers. Due to the high co-occurrence of 
heavy smoking and alcoholism it is unlikely that 
the never smoker group contains many former 
alcoholics. Moreover, by including only never 
smokers we excluded the potential confound-
ing association signal emerging from smoking 
and CPD. Limiting the analysis to never smok-
ers (N=16,786) did not have a notable impact 
on the results, suggesting that locus 3 
(rs588765) is associated specifically with regu-
lar alcohol use. Although the actual effect size 
of locus 3 (OR=1.18) is modest, this finding pro-
vides new direction for the research of CHRNA5-
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CHRNA3-CHRNB4 locus 3 and suggests that 
the effects of alcohol may partially be mediated 
through cholinergic receptors and their down-
stream transmitter molecules. The association 
did not replicate in the NAG-OZALC or YFS sam-
ple, possibly due to the significantly smaller 
sample sizes when compared to the study 
sample. 
Locus 3 has previously been associated with 
DSM-IV alcohol dependence in African 
Americans [17] and in the Collaborative Study 
on the Genetics of Alcoholism (COGA) sample 
[20]. To the best of our knowledge, the current 
study is the first population based study to 
examine association between regular alcohol 
use and the 15q25.1 region, and to report an 
association with locus 3. Although our sample 
is adequately sized, unascertained, and geneti-
cally homogenous, we acknowledge the likely 
underrepresentation of severely alcohol and 
nicotine addicted individuals who are less likely 
to participate in health-related surveys. Their 
absence is unlikely to explain the association 
with the drinker status. Further studies are 
needed to elucidate and verify the associations 
between the 15q25.1 region and alcohol relat-
ed traits, and the specific role of locus 3.
Within the past few years, several independent 
studies, large-scale meta-analyses, and repli-
cation studies have reported association 
between the CHRNA5-CHRNA3-CHRNB4 gene 
cluster on chromosome 15q25.1 and smoking-
related traits and diseases, such as nicotine 
dependence, CPD, chronic obstructive pulmo-
nary disease, and lung cancer [7-10, 23, 24]. 
Two distinct loci have been consistently high-
lighted; locus 1 tagged by rs16969968 or 
rs1051730 and locus 2 tagged by rs578776. 
Several association studies, including the cur-
rent study, suggest that locus 1 is a consistent 
risk factor for smoking behavior with the minor 
allele predisposing a smoker to smoke more, 
become dependent on nicotine, and, as a con-
sequence, even develop a smoking related dis-
ease. Evidence for a role of locus 1 in alcohol-
related traits has been much more controversial. 
In the current study, the lack of difference in 
the analyses of CPD with and without adjust-
ment for alcohol use suggests that the effect of 
rs16969968 is specific to smoking. Locus 2, 
on the other hand, seems to be protective 
against smoking. In the current study locus 2 
showed an effect size of an OR 0.8, which is in 
line with previous studies [7, 18]. The role of 
locus 3 (tagged by rs588765) in smoking 
behavior remains unconfirmed. The current 
study failed to achieve significant association 
between rs588765 and dichotomous CPD, but 
association was detected with quantitative 
CPD. Locus 3 has previously been associated 
with alcohol dependence [17, 20] and it is also 
associated with altered levels of CHRNA5 
mRNA [20]. The current study provided evi-
dence of a novel association between locus 3 
(rs588765) on 15q25.1 and alcohol use 
defined as abstainers and low-frequency drink-
ers versus drinkers in a large Finnish popula-
tion sample. Limiting the analysis to never 
smokers did not have an impact on the results, 
suggesting that the effect of rs588765 may be 
specific to alcohol use.
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